Delta variant of Covid-19 has now surfaced in 132 countries and territories. Dr. Tedros of WHO stated on Friday that on average, infections increased by 80 percent over the past four weeks in Five of the Six World Health Organisations regions.
“Delta is a warning: it’s a warning that the virus is evolving but it is also a call to action that we need to move now before more dangerous variants emerge,” the WHO’s emergencies director Michael Ryan told a press conference.
WHO chief Tedros Adhanom Ghebreyesus added: “So far, four variants of concern have emerged — and there will be more as long as the virus continues to spread.”
Tedros said that on average, infections increased by 80 percent over the past four weeks in five of the six WHO regions.
The WHO wants every country to have vaccinated at least 10% of its population by the end of September; at least 40% by the end of this year, and 70% by the middle of 2022.
The Delta variant of Covid-19 is a warning to the world to suppress the virus quickly before it mutates again into something even worse, the WHO said Friday.
“The virus has got fitter, the virus has got faster. The game plan still works, but we need to implement and execute our game plan much more efficiently and much more effectively then we’ve ever done before.”
The highly transmissible variant, first detected in India, has now surfaced in 132 countries and territories, the World Health Organization said
WHO chief Tedros Adhanom Ghebreyesus added: “So far, four variants of concern have emerged — and there will be more as long as the virus continues to spread.”
The World Health Organisation wants every country to have vaccinated at least 10 percent of its population by the end of September; at least 40 percent by the end of this year, and 70 percent by the middle of 2022.
Indian Vaccine COVAXIN has shown stronger antibody response against beta and delta variant
Bharat Biotech’s covid-19 vaccine Covaxin elicits stronger antibody response against the beta and delta variants of SARS CoV2 virus in comparison to post natural infection, showed a study done by Indian Council of Medical Research-National Institute of Virology (NIV).
The study was published in the Journal of Travel Medicine under Oxford Academic on Wednesday. The scientists at ICMR and Bharat Biotech collected blood samples from 20 covid recovered cases and 17 people vaccinated with two doses of Covaxin against the beta and delta variants and compared with the prototype D614G variant (wild).
More than four billion doses of Covid-19 vaccines have now been administered globally according to reports.
